Why Choose EverydayMeds for Your 1.7mg Wegovy Prescription?
Understanding When You Can Start Wegovy at 1.7mg Dose
The question "can I start Wegovy at 1.7mg" reflects a common misunderstanding about semaglutide dosing protocols. Wegovy cannot be initiated at 1.7mg due to MHRA-mandated dose escalation requirements designed to minimise gastrointestinal side effects. Patients must begin with 0.25mg for weeks 1-4, progress to 0.5mg (weeks 5-8), then 1mg (weeks 9-12) before reaching the 1.7mg dose during weeks 13-16.
However, if you're already following the proper escalation schedule and require Wegovy 1.7mg for your current phase, EverydayMeds provides the UK's most competitive pricing structure. Our £139.99 price point represents exceptional value for this penultimate dose, positioning you just one step away from the 2.4mg maintenance phase. This price includes full clinical assessment, prescriber review, and temperature-controlled delivery to your door.
Wegovy 1.7mg Pricing and Bundle Value at UK's Lowest Rates
EverydayMeds has strategically positioned itself as the UK's price leader for Wegovy 1.7mg, offering single pens at £139.99 after applying discount codes at checkout. New customers benefit from code FIRST40, while returning patients use DOSE25 to access these industry-beating rates. This pricing includes comprehensive clinical assessment, prescriber review, and next-day cold-chain delivery - services that competitors often charge separately.
For patients planning their transition to maintenance dosing, our Elevate Duo bundle provides both 1.7mg and 2.4mg pens for £369.99, ensuring seamless progression without supply interruption. Alternatively, patients requiring extended time at 1.7mg can choose our Consistency 1.7mg bundle (two pens) for £309.99, ideal for those experiencing optimal results at this dose level and wanting to delay progression to maintenance.
Clinical Evidence Supporting Wegovy 1.7mg in Weight Management
The question "can I start Wegovy at 1.7mg" often arises from patients eager to reach therapeutic doses quickly. However, clinical evidence from the STEP trials demonstrates that gradual dose escalation optimises both efficacy and tolerability. In STEP 1, patients following the complete dose escalation protocol achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, alongside a reduced-calorie diet and increased physical activity.
The 1.7mg dose represents a critical transition point where many patients begin experiencing peak appetite suppression effects. STEP trial data suggests this dose provides substantial GLP-1 receptor activation while maintaining acceptable side effect profiles, preparing patients for the full 2.4mg maintenance dose where maximum therapeutic benefit is typically achieved.
How Wegovy's GLP-1 Mechanism Works at 1.7mg Dosing
Understanding why you cannot start Wegovy at 1.7mg requires appreciating semaglutide's mechanism of action as a GLP-1 receptor agonist. This prescription-only medicine mimics natural incretin hormones, binding to GLP-1 receptors in the brain's appetite control centres and throughout the digestive system. At 1.7mg dosing, semaglutide provides significant appetite reduction and enhanced satiety signals, helping patients feel satisfied with smaller meal portions. The gradual dose escalation allows your body's GLP-1 receptors to adapt progressively, minimising common side effects like nausea, vomiting, and digestive discomfort. By weeks 13-16 when patients reach 1.7mg, their systems have typically adjusted to semaglutide's effects, enabling them to tolerate this higher dose while experiencing substantial weight management benefits alongside their reduced-calorie diet and exercise programme.
Streamlined Ordering Process for Wegovy 1.7mg Prescriptions
Patients asking "can I start Wegovy at 1.7mg" can quickly determine their appropriate dose through EverydayMeds' efficient prescribing process. Our 3-minute online clinical assessment captures essential medical history, current medications, and weight management goals, enabling our GPhC-registered prescribers (#9012878) to make informed dosing decisions. Standard prescriber review takes 3 working days, though express 24-hour review is available for urgent requirements. Once approved, your Wegovy 1.7mg pen ships via next-day delivery using specialised cold-chain logistics to maintain the 2-8°C temperature requirements. Our pharmaceutical-grade packaging ensures your medication arrives in optimal condition, ready for refrigerated storage until your scheduled injection day.
Proper Storage and Practical Considerations for 1.7mg Wegovy
Wegovy 1.7mg pens require refrigeration at 2-8°C before first use, though they maintain stability for up to 6 weeks at room temperature below 30°C once removed from refrigerated storage. This flexibility provides significant advantages over alternative treatments like Mounjaro, which only tolerates 21 days at room temperature. The FlexTouch pen delivery system pre-measures your 1.7mg dose, eliminating measurement errors and simplifying weekly injections. Patients should rotate injection sites between thigh, abdomen, or upper arm to prevent lipodystrophy, and never attempt to skip directly to 1.7mg without completing prior escalation phases. Each pen contains exactly four weeks of treatment at 1.7mg dosing, perfectly aligning with the standard weeks 13-16 protocol before progressing to 2.4mg maintenance.
Strategic Advantages of Choosing 1.7mg Wegovy at EverydayMeds' Pricing
The inquiry "can I start Wegovy at 1.7mg" often stems from cost-conscious patients seeking to minimise their investment in lower doses. However, EverydayMeds' competitive pricing structure makes the complete escalation journey financially accessible. At £139.99 for 1.7mg, patients receive exceptional value during this crucial transition phase where appetite suppression effects typically intensify significantly.
Our strategic bundle offerings, particularly the Elevate Duo at £369.99, provide both 1.7mg and maintenance 2.4mg doses with convenient single-order processing. This approach eliminates repeat assessment fees and ensures uninterrupted treatment progression, factors that patients cannot achieve when attempting to circumvent proper dose escalation protocols.
Complete Your Wegovy Journey with Confidence and Best Value
While you cannot start Wegovy at 1.7mg due to mandatory escalation requirements, EverydayMeds ensures your progression to this crucial dose remains affordable and seamless. Our £139.99 pricing represents the UK's most competitive rate for genuine Novo Nordisk Wegovy 1.7mg, supported by comprehensive clinical care and next-day delivery. Apply code FIRST40 for new customers or DOSE25 for returning patients at checkout to access these industry-leading prices. Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your clinical assessment today, with prescriber review and cold-chain delivery ensuring your weight management journey continues without interruption. Our GPhC-registered clinical team provides ongoing support throughout your treatment, ensuring optimal outcomes as you approach the maintenance phase of your Wegovy programme.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
